Pdl Biopharma Inc (PDLI)

SG&A Expenses

$39.60M

TTM · Period ending: · USD

PDLI logo

PDLI SG&A Expenses

Latest reported$39.60M
PDLI TTM SG&A Expenses ($9.80M → $39.60M)
High-resolution chart · PNG

PDLI sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Pdl Biopharma Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
39,603,000
53,407,000
55,007,000
54,080,000
48,343,000
51,219,000
58,577,000
62,559,000
70,045,000
70,348,000
65,338,000
63,324,000
60,171,000
53,595,000
45,642,000
40,328,000
39,749,000
37,792,000
38,270,000
36,090,000
41,271,000
38,507,000
37,998,000
34,914,000
25,049,000
27,288,000
27,151,000
29,755,000
29,626,000
27,348,000
25,710,000
24,410,000
20,915,000
18,708,000
16,824,000
16,211,000
116,530,000
124,200,000
129,759,000
133,896,000
34,866,000
29,011,000
25,781,000
21,064,000
31,538,000
44,828,000
56,083,000
25,683,000
57,601,000
79,265,000
99,655,000
163,303,000
224,168,000
212,287,000
201,288,000
195,506,000
130,886,000
144,578,000
138,148,000
113,655,000
78,116,000
43,760,000
31,404,000
31,806,000
32,176,000
31,208,000
31,111,000
28,113,000
24,531,000
22,570,000
20,006,000
19,093,000
17,999,000
17,000,000
16,263,000
15,726,000
16,501,000
16,718,000
16,619,000
16,308,000
14,515,000
13,862,000
13,309,000
13,300,000
13,800,000
13,600,000
13,100,000
12,400,000
11,300,000
10,600,000
10,100,000
9,800,000
9,500,000
9,300,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.